CatalYm

Planegg, Germany

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

Jul 2024

Series D

Top Investors

Omega FundsCanaan PartnersForbion Capital PartnersBrandon CapitalBioGeneration Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are CatalYm's investors?

CatalYm's investors include Omega Funds, Canaan Partners, Forbion Capital Partners, Brandon Capital, BioGeneration Ventures.

Where is CatalYm headquartered?

CatalYm is headquartered in Planegg, Germany.

What does CatalYm do?

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

What stage is CatalYm at?

CatalYm is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 16, 2024.

MLA

"CatalYm — Funding & Investors." VCBacked, July 16, 2024, https://www.vcbacked.co/company/catalym. Accessed July 1, 2026.

APA

VCBacked. (2024). CatalYm — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/catalym

Wikipedia (cite web)

{{cite web |title=CatalYm — Funding & Investors |url=https://www.vcbacked.co/company/catalym |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 16, 2024.